Product NewsLife Sciences Eurofins Panlabs Strengthens Drug Discovery Services with GE Healthcare’s Cytiva™ Cardiomyocytes
Industry NewsDrug discovery > Target Discovery Eurofins Panlabs Strengthens Drug Discovery Services with GE Healthcare’s Cytiva™ Cardiomyocytes
Application NoteCardiomyocyte Beating and Cytotoxicity Assays on the SpectraMax i3 Multi-Mode Microplate Platform with SpectraMax MiniMax Imaging Cytometer
Application NotePhenotypic Characterization of Toxic Compound Effects on Cardiomyocytes Derived from iPSCs
Application NoteAssessment of Drug Effects on Cardiomyocyte Physiology Using Human iPSC-Derived Cardiac Spheroids
Application NoteMonitoring BNP Expresion and Cell Size to Determine Hypertrophic Response in Human Cardiomyocytes
Industry NewsBMG LABTECH and InvivoSciences Initiate Market Collaboration to Accelerate Drug Discovery in Engineered 3D Tissues
Industry NewsEurofins Panlabs Strengthens Drug Discovery Services with GE Healthcare’s Cytiva™ Cardiomyocytes
